These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9023825)

  • 1. Histopathologic prognostic factors in early stage cervical carcinoma.
    Benda JA
    J Natl Cancer Inst Monogr; 1996; (21):27-34. PubMed ID: 9023825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma.
    Kristensen GB; Abeler VM; Risberg B; Trop C; Bryne M
    Gynecol Oncol; 1999 Aug; 74(2):245-51. PubMed ID: 10419739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missing association between telomerase activity and clinicopathological features in patients with early stage carcinoma of the cervix.
    Santos-Filho AS; Triginelli SA; Traiman P; Cunha-Melo JR; Silva-Filho AL
    Arch Gynecol Obstet; 2007 Jan; 275(1):13-7. PubMed ID: 16858573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic grade and prognosis of carcinoma of the cervix.
    Chung CK; Stryker JA; Ward SP; Nahhas WA; Mortel R
    Obstet Gynecol; 1981 May; 57(5):636-42. PubMed ID: 7219913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of mitotic activity, eosinophilic and inflammatory reaction in stage I cancer of the uterine cervix.
    Ayhan A; Altintaş A; Tuncer ZS; Küçükali T; Yüce K
    Eur J Surg Oncol; 1992 Jun; 18(3):264-6. PubMed ID: 1607039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
    Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
    Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T; Aksu MF; Cetinkaya MB
    Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis.
    Tsai CC; Liu YS; Huang EY; Huang SC; Chang HW; Tseng CW; ChangChien CC
    Gynecol Oncol; 2006 Mar; 100(3):591-5. PubMed ID: 16290001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.
    Roman LD; Felix JC; Muderspach LI; Varkey T; Burnett AF; Qian D; Morrow CP
    Gynecol Oncol; 1998 Mar; 68(3):220-5. PubMed ID: 9570969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for relapse and pelvic lymph node metastases in early stage I adenocarcinoma of the cervix.
    Covens A; Kirby J; Shaw P; Chapman W; Franseen E
    Gynecol Oncol; 1999 Sep; 74(3):423-7. PubMed ID: 10479503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen.
    Obermair A; Wanner C; Bilgi S; Speiser P; Reisenberger K; Kaider A; Kainz C; Leodolter S; Breitenecker G; Gitsch G
    Cancer; 1998 Feb; 82(4):689-96. PubMed ID: 9477101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.